Actively Recruiting
Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
Led by Dana-Farber Cancer Institute · Updated on 2026-01-29
21
Participants Needed
1
Research Sites
41 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research is being done to determine whether a 12-week virtual Tai Chi training program, designed to improve balance and small nerve fiber function, is feasible and acceptable among cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN).
CONDITIONS
Official Title
Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years old and older
- Cancer survivors with no evidence of disease (cancer)
- Completed neurotoxic chemotherapy (platinum agents, taxanes, vinca alkaloids, or bortezomib) at least three months before enrollment
- Diagnosed with CIPN based on symptom history, loss of deep tendon reflexes, or presence of symmetrical stocking-glove pain, numbness, or paresthesia
- Self-reported balance difficulties or fear of falling due to CIPN
- On a stable medication regimen for anti-neuropathy or pain medications for at least three months
- Eastern Cooperative Oncology Group (ECOG) Performance Status Scale score of 2 or less
- Willing to follow all study procedures including randomization and two in-person visits to Dana-Farber Cancer Institute
- Willing to avoid starting new pain medications during the study
- Individuals receiving endocrine therapy or targeted/antibody therapy (such as trastuzumab, pertuzumab, or immunotherapy) are eligible
You will not qualify if you...
- Received physical therapy or Tai Chi training specifically for CIPN in the past three months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
Actively Recruiting
Research Team
T
Ting Bao, MD
CONTACT
N
Natalie Viyaran
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here